3 Reasons CRL is Risky and 1 Stock to Buy Instead

Over the past six months, Charles River Laboratories has been a great trade, beating the S&P 500 by 7.5%. Its stock price has climbed to $168.91, representing a healthy 10.5% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.